Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018)

Eton Pharmaceuticals' (ETON) quarterly Preferred Dividend Payments came in at $22.3 million in Q4 2018, up 2963.37% quarter-over-quarter from $729000.0 in Q3 2018.

Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018) Analysis & Trends

Eton Pharmaceuticals has disclosed Preferred Dividend Payments across 1 years of filings, most recently posting $22.3 million for Q4 2018.

  • Preferred Dividend Payments for Q4 2018 came in at $22.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $24.5 million (changed N/A YoY), and the FY2018 annual result was $24.5 million, up 1551.31% from the prior year.
  • Preferred Dividend Payments came in at $22.3 million for Q4 2018 at Eton Pharmaceuticals, up from $729000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $22.3 million in Q4 2018 to a low of $706000.0 in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Eton Pharmaceuticals 806.97 Mn 781.03 Mn 13.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 22.33 Mn
Sep 30, 2018 729,000.00
Jun 30, 2018 722,000.00
Mar 31, 2018 706,000.00